Developer docs
API playgroundTry for free, no card

Search company profiles

Cyberdyne

Full company profile

uuid0007ydj

Namestring
Cyberdyne
Legal namestring
CYBERDYNE株式会社
Websiteurl
cyberdyne.jp
Company typeenum
Public
Founded yearint
2004
Descriptiontext

Cyberdyne, Inc. (TYO: 7779) is a Japan-based public company founded in 2004 by Professor Yoshiyuki Sankai as a University of Tsukuba-originated venture, developing and commercializing the world's first wearable cyborg, HAL (Hybrid Assistive Limb). Its core technology, HCPS Cybernics with Physical AI, fuses bio-electric signal processing, AI, robotics, and information systems to enable devices that read the wearer's voluntary motor intention from skin-surface bio-electrical signals and provide real-time motion assistance — the basis of Cybernics Treatment, a functional improvement and regeneration therapy for spinal cord injury, stroke, cerebral palsy, and other neurological conditions.

The company's revenue model spans four streams: (1) medical device sales and rentals of HAL variants (Lower Limb Type, Single Joint Type) to hospitals and rehabilitation centers, covered by public health insurance in Japan and workers' compensation in Germany; (2) recurring Neuro HALFIT subscription-style training services delivered through 18 Robocare Centers across Japan and a home rental e-commerce channel; (3) large international government contracts exemplified by the PERKESO Malaysia deployment of 65 HAL units in a single facility (182 units across 15 facilities nationally); and (4) ecosystem returns from the ¥10 billion CEJ Fund (plus a new ¥10B Pegasus Tech Ventures CVC fund) investing in Cybernics-adjacent startups. Customers include healthcare institutions (NTUH, RISE Healthcare Group), national social security organizations (PERKESO, BG RCI Germany), and government agencies (FDMA of Japan).

The company holds regulatory approvals in 20+ countries (PMDA, FDA, CE Mark, ISO 13485, ISO 13482) and operates wholly-owned subsidiaries in the U.S., Germany, and Malaysia, with a global footprint across Japan, Malaysia, USA, Germany, Taiwan, and Thailand. FY2026 revenue was approximately ¥24.2 billion (~US$160M) with operating losses compressing sharply year-over-year and EBITDA turning positive, signaling a transition toward operational sustainability.

Short descriptiontext

Cyberdyne develops and commercializes HAL, the world's first wearable cyborg, plus the Neuro HALFIT service program, serving hospitals, rehabilitation centers, and government healthcare systems across 20+ countries for neurological rehabilitation and labor support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMinami, Japan
HQ citystring
Minami
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable cyborg robots, medical robotics devices, neurorehabilitation technology, bio-electrical signal processing, assistive medical equipment
Industry2 codes
1Healthcare & Assistive Robotics
CodeHDAAAIACPrimaryYes
2Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports)
CodeHLAHAMACPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Robotics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Sales and Rental
TypeHardware Sales
Description

CYBERDYNE generates revenue through sales and rental of HAL medical devices to hospitals, rehabilitation centers, and healthcare facilities. The company offers both purchase and rental models, including home rental programs for individual use. Medical HAL devices are approved and covered by public health insurance in Japan and covered by workers' compensation insurance in Germany.

cyberdyne.jp
2Neuro HALFIT Services
TypeSubscription Recurring
Description

Subscription-style services at Robocare Centers providing Neuro HALFIT training programs. Revenue generated through session-based fees for one-on-one training programs, with shareholder benefit discount programs available. 18 Robocare Centers operating across Japan.

cyberdyne.jp
3International Projects and Government Contracts
TypeHardware Sales
Description

Large-scale national deployment projects such as the PERKESO National Neuro-Robotics Rehabilitation Centre in Malaysia, featuring 65 HAL units. Revenue from international government healthcare systems and social security organizations.

kingsresearch.com
4C-Startup/CEJ Fund Investment Returns
TypeLicensing Royalties
Description

CEJ Fund (approximately ¥10 billion) invests in startups in Cybernics-related fields including medicine, healthcare, robotics, AI, Big Data, IoH/IoT. Fund management fees and investment returns contribute to revenue ecosystem.

cyberdyne.jp
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Cyin福祉用 - ¥600,000 (non-taxable)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Retail price for Cyin welfare device. May be covered under special assistive equipment subsidies through local government programs.

cyberdyne.jp
2HAL Try-on Experience - Lumbar Type: ¥10,000 flat rate (up to 2 people)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

HAL Lumbar Type try-on experience: Flat rate ¥10,000 for up to 2 people, additional participants ¥3,000 each. Lower-limb type: ¥15,000 per person. 45-120 minute sessions available.

cyberdyne.jp
3Group Tour at CYBERDYNE STUDIO
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Adults: ¥1,400 per person, Students: ¥1,100 per person, Preschool children: Free. Includes original souvenir goods.

cyberdyne.jp
4Shareholder Benefits - Neuro HALFIT Programs
ModelSubscriptionBilling cadenceAnnual
Notes

Course A: Neuro HALFIT at Home Personal Rental with ¥10,000-¥80,000 discount based on shares held. Course B: Neuro HALFIT One-on-One with 10-50% discount. First-Time Benefit: One free session for 1,000+ share holders.

cyberdyne.jp
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1HAL (Hybrid Assistive Limb)
Description

World's first wearable cyborg; a robotic suit that reads bio-electrical signals from the wearer's skin surface to assist joint movement. Available in lower limb, single joint, and lumbar type variants for medical and non-medical use.

cyberdyne.jp
+8 more records
Core offering1 text field

Cyberdyne develops, manufactures, and sells the wearable cyborg HAL (Hybrid Assistive Limb) and related Cybernics technologies for medical rehabilitation, elderly care, labor support, and consumer wellbeing. It sells and rents HAL devices directly to hospitals, rehabilitation centers, and government healthcare systems, while also running a Robocare Center service network delivering Neuro HALFIT training programs to individuals. Supplementary products include the Cyvis M100 medical ECG vital sensor, Cyin assistive communication device, Acoustic X photoacoustic imaging system, and autonomous cleaning and transport robots.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Patients with spinal cord injuries able to walk with walker after HAL treatment (e.g., Philippe von Gliszynski walked 1,000+ meters after training)
+2 more records
Product overview1 text field

CYBERDYNE offers a comprehensive suite of products centered on its core technology, 'HCPS Cybernics with Physical AI' - a human-centered approach that fuses bio/medical sciences with AI, robotics, and information systems. The flagship product is HAL (Hybrid Assistive Limb), the world's first wearable cyborg that reads bio-electrical signals to provide motion assistance. HAL is available in medical versions (Lower Limb Type, Single Joint Type) and non-medical/consumer versions (Lumbar Type for care and labor support, Lower Limb and Single Joint for wellbeing). Supporting products include Cyvis M100 (medical ECG sensor), Cyin (communication device for disabled individuals), and Acoustic X (photoacoustic imaging). The company also provides Neuro HALFIT service programs at Robocare Centers and at home, along with autonomous cleaning and transport robots. CYBERDYNE operates experience facilities (CYBERDYNE STUDIO and MIRAI ROBO SQUARE) for public engagement.

Product and service15 records
1Medical HAL Lower Limb Type
CategoryMedical Device Product
Description

Wearable cyborg for medical lower limb rehabilitation targeting patients with spinal cord injuries, stroke, and neurological disorders. Available in standard and small sizes.

2Medical HAL Single Joint Type
CategoryMedical Device Product
Description

Ultra-lightweight (1.5kg) single joint assistance device for intensive training of specific joints (elbow, knee, ankle) in post-operative rehabilitation.

3HAL Lumbar Type (Care/Wellbeing)
CategoryNon-Medical Product
Description

Waist-mounted HAL for independence support and care assistance, helping users with sit-to-stand movements and walking while reducing caregiver burden.

4HAL Lumbar Type (Labor Support)
CategoryNon-Medical Product
Description

Workplace version of HAL Lumbar Type designed to reduce physical strain during lifting, carrying, and repetitive tasks, including slim models for confined spaces and disaster response applications.

5HAL Lower Limb Type (Wellbeing)
CategoryNon-Medical Product
Description

Non-medical version of HAL Lower Limb for general wellness and independence support in daily living activities.

6HAL Single Joint Type (Wellbeing)
CategoryNon-Medical Product
Description

Non-medical single joint assistance device for intensive movement training of specific joints for general wellness purposes.

7Neuro HALFIT
CategoryService/Program
Description

Subscription-style comprehensive exercise training program using HAL at Robocare Centers or at home, promoting improvement in brain-nerve-muscular system functions through interactive bio-feedback therapy.

8Cyvis M100 Medical Vital Sensor
CategoryMedical Device Product
Description

Small Holter ECG medical vital sensor capable of approximately 10 days of electrocardiogram measurement on a single charge; cleared as a medical device in Japan with public health insurance coverage.

9Cyin (Cyin Welfare Device)
CategoryMedical Device Product
Description

Innovative communication interface for severely disabled individuals who cannot speak or move, using faint bio-electrical signals from the brain to muscles (motor unit action potentials) to enable yes/no communication and environmental control.

10Acoustic X Photoacoustic Imaging System
CategoryMedical Device Product
Description

Photoacoustic imaging system that integrates optical excitation with ultrasound detection for high-resolution tissue imaging in medical diagnostics.

11HALTREAD Treadmill Equipment
CategoryRehabilitation Equipment
Description

Treadmill equipment designed for HAL-assisted gait training and rehabilitation exercises.

12CL02 Sterilization/Cleaning Robot
CategoryRobotics Product
Description

Autonomous cleaning and sterilization robot for healthcare facilities and commercial environments.

13Transport Robot
CategoryRobotics Product
Description

Autonomous mobile robot for material transport and logistics in healthcare and industrial settings.

14Jukusui Sleep Alarm Device
CategoryWellbeing Product
Description

Sleep alarm device designed to improve sleep quality and monitor sleep patterns, operated through subsidiary C2 Inc.

15MIRAI ROBO SQUARE Exhibition Facility
CategoryExperience Facility
Description

Permanent exhibition facility in Tokyo Shinagawa showcasing Cybernics technologies and HAL to visitors.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Japan Fire and Disaster Management Agency (FDMA)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-05
Description

Firefighting-specific model of HAL Lumbar Type selected for field verification of advanced technologies in disaster response operations. CYBERDYNE expanding into disaster prevention and firefighting sectors.

cyberdyne.jp
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-10
Description

Comprehensive collaboration agreement for social implementation of HCPS-Integrated Cybernics technology in Malaysia. Part of broader strategy to expand Cybernics ecosystem across ASEAN region.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Strategic MoU for collaborative research in Cybernics and Physical AI. Partnership includes plans to establish Pittsburgh-based joint venture and launch Cyvis health sensor in U.S. market following Japanese medical device approval. Aims to accelerate integration of CYBERDYNE products into U.S. market using Pittsburgh as base for global expansion.

4Thailand Institute of Geriatric Medicine (IGM-DMS)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

Agreement to promote Cybernics Medical and Healthcare Innovation across ASEAN. Part of regional expansion strategy targeting elderly care and rehabilitation markets in Southeast Asia.

cyberdyne.jp
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-18
Description

MoU signed with National Taiwan University and University of Tsukuba for international collaboration on Cybernics Medical and Healthcare Innovation. National Taiwan University Hospital delegation visited CYBERDYNE headquarters to explore partnership opportunities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Long-term collaboration since 2018 for large-scale deployment of HAL systems. PERKESO became first organization in Southeast Asia to introduce HAL. National Neuro-Robotics and Cybernics Rehabilitation Centre opened June 2026 with 65 HAL units - one of world's largest single-facility deployments. Collaboration enables patients to access Cybernics Treatment through PERKESO's social security system.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Business partner in Germany for providing Cybernics Treatment at Cyberdyne Care Robotics GmbH in Bochum. Workers' compensation insurance covers HAL treatment costs (approximately €500 per treatment x 60 sessions) for patients with spinal cord injury and stroke.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S.-listed developer of wearable exoskeletons for medical rehabilitation (stroke, spinal cord injury) and industrial use. Directly comparable to HAL as a hospital- and clinic-deployed lower-limb exoskeleton targeting similar neuro-rehabilitation indications.

TypeDirect peer
Description

Maker of FDA-cleared powered exoskeletons for spinal cord injury and stroke rehabilitation, plus a soft exosuit line. Closely competes with HAL in medical lower-limb neurorehabilitation and shares similar reimbursement-driven go-to-market in the U.S. and EU.

TypeDirect peer
Description

German prosthetics and orthotics leader that acquired suitX, offering modular exoskeletons for industrial and medical applications. Comparable to CYBERDYNE as a wearable robotic-assist player with strong European reimbursement and orthopedic channel access.

TypeDirect peer
Description

Industrial conglomerate whose Indego line delivers FDA-cleared powered exoskeletons for clinical and personal use. Competes directly with HAL in U.S. rehabilitation centers and shares the orthotic-and-assistive positioning.

TypeBroad incumbent
Description

Large mobility incumbent with a Walking Assist Device for gait rehabilitation and broader humanoid robotics programs (Asimo). Comparable to HAL as a wearable gait-assist technology, though distributed through a much larger automotive and mobility platform.

TypeEmerging player
Description

French developer of self-balancing Atalante personal and clinical exoskeletons. Comparable to HAL in the powered lower-limb exoskeleton category with a focus on stroke and spinal cord injury, and competing for European hospital and home-use accounts.

TypeEmerging player
Description

China-based rehab robotics company with ExoMotus exoskeletons and a growing global footprint. Comparable to HAL as a hospital-deployed rehabilitation exoskeleton targeting similar neurological indications, with strong Asia-Pacific overlap.

TypeEmerging player
Description

U.S. developer of wearable industrial robots and Guardian exoskeletons for workforce augmentation. Comparable to HAL's labor-support and lumbar-assist applications for industrial and defense end-users.

TypeEmerging player
Description

European exoskeleton specialist focused on occupational lumbar support (Cray X) for industrial and logistics workers. Direct competitor to HAL Lumbar Type in the labor-support and workplace-safety segment.

TypeBroad incumbent
Description

Large mobility conglomerate with wearable robotic exoskeletons and broader humanoid/robotics programs through Boston Dynamics. Adjacent incumbent with overlapping ambition in Physical AI and service/industrial robots, though not a direct medical competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment25 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cyberdyne

Medical Roboticscyberdyne.jp

Cyberdyne develops and commercializes HAL, the world's first wearable cyborg, plus the Neuro HALFIT service program, serving hospitals, rehabilitation centers, and government healthcare systems across 20+ countries for neurological rehabilitation and labor support.

What Cyberdyne does

Cyberdyne, Inc. (TYO: 7779) is a Japan-based public company founded in 2004 by Professor Yoshiyuki Sankai as a University of Tsukuba-originated venture, developing and commercializing the world's first wearable cyborg, HAL (Hybrid Assistive Limb). Its core technology, HCPS Cybernics with Physical AI, fuses bio-electric signal processing, AI, robotics, and information systems to enable devices that read the wearer's voluntary motor intention from skin-surface bio-electrical signals and provide real-time motion assistance — the basis of Cybernics Treatment, a functional improvement and regeneration therapy for spinal cord injury, stroke, cerebral palsy, and other neurological conditions.

The company's revenue model spans four streams: (1) medical device sales and rentals of HAL variants (Lower Limb Type, Single Joint Type) to hospitals and rehabilitation centers, covered by public health insurance in Japan and workers' compensation in Germany; (2) recurring Neuro HALFIT subscription-style training services delivered through 18 Robocare Centers across Japan and a home rental e-commerce channel; (3) large international government contracts exemplified by the PERKESO Malaysia deployment of 65 HAL units in a single facility (182 units across 15 facilities nationally); and (4) ecosystem returns from the ¥10 billion CEJ Fund (plus a new ¥10B Pegasus Tech Ventures CVC fund) investing in Cybernics-adjacent startups. Customers include healthcare institutions (NTUH, RISE Healthcare Group), national social security organizations (PERKESO, BG RCI Germany), and government agencies (FDMA of Japan).

The company holds regulatory approvals in 20+ countries (PMDA, FDA, CE Mark, ISO 13485, ISO 13482) and operates wholly-owned subsidiaries in the U.S., Germany, and Malaysia, with a global footprint across Japan, Malaysia, USA, Germany, Taiwan, and Thailand. FY2026 revenue was approximately ¥24.2 billion (~US$160M) with operating losses compressing sharply year-over-year and EBITDA turning positive, signaling a transition toward operational sustainability.

Cyberdyne firmographics

Firmographics
Name
Cyberdyne
Legal name
CYBERDYNE株式会社
Website
https://cyberdyne.jp
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
101–250 employees
Short description
Cyberdyne develops and commercializes HAL, the world's first wearable cyborg, plus the Neuro HALFIT service program, serving hospitals, rehabilitation centers, and government healthcare systems across 20+ countries for neurological rehabilitation and labor support.
Ownership category
akta.pro rank

Cyberdyne industry classification

Industry
Product category
Medical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Healthcare & Assistive Robotics (HDAAAIAC)
akta.pro secondary industry
Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC)

Keywords

  • Wearable cyborg robots
  • Medical robotics devices
  • Neurorehabilitation technology
  • Bio-electrical signal processing
  • Assistive medical equipment

Where Cyberdyne is headquartered

Location

Headquarters

HQ city
Minami
HQ country
Japan
HQ region
Asia

Offices9 records

Markets served

Cyberdyne business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales and Rental: CYBERDYNE generates revenue through sales and rental of HAL medical devices to hospitals, rehabilitation centers, and healthcare facilities. The company offers both purchase and rental models, including home rental programs for individual use. Medical HAL devices are approved and covered by public health insurance in Japan and covered by workers' compensation insurance in Germany.
  2. Neuro HALFIT Services: Subscription-style services at Robocare Centers providing Neuro HALFIT training programs. Revenue generated through session-based fees for one-on-one training programs, with shareholder benefit discount programs available. 18 Robocare Centers operating across Japan.
  3. International Projects and Government Contracts: Large-scale national deployment projects such as the PERKESO National Neuro-Robotics Rehabilitation Centre in Malaysia, featuring 65 HAL units. Revenue from international government healthcare systems and social security organizations.
  4. C-Startup/CEJ Fund Investment Returns: CEJ Fund (approximately ¥10 billion) invests in startups in Cybernics-related fields including medicine, healthcare, robotics, AI, Big Data, IoH/IoT. Fund management fees and investment returns contribute to revenue ecosystem.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goCyin福祉用 - ¥600,000 (non-taxable)
Unit PricingPay-as-you-goHAL Try-on Experience - Lumbar Type: ¥10,000 flat rate (up to 2 people)
Unit PricingPay-as-you-goGroup Tour at CYBERDYNE STUDIO
SubscriptionAnnualShareholder Benefits - Neuro HALFIT Programs

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Cyberdyne product offering

Product offering

Core offering

Cyberdyne develops, manufactures, and sells the wearable cyborg HAL (Hybrid Assistive Limb) and related Cybernics technologies for medical rehabilitation, elderly care, labor support, and consumer wellbeing. It sells and rents HAL devices directly to hospitals, rehabilitation centers, and government healthcare systems, while also running a Robocare Center service network delivering Neuro HALFIT training programs to individuals. Supplementary products include the Cyvis M100 medical ECG vital sensor, Cyin assistive communication device, Acoustic X photoacoustic imaging system, and autonomous cleaning and transport robots.

Product overview

CYBERDYNE offers a comprehensive suite of products centered on its core technology, 'HCPS Cybernics with Physical AI' - a human-centered approach that fuses bio/medical sciences with AI, robotics, and information systems. The flagship product is HAL (Hybrid Assistive Limb), the world's first wearable cyborg that reads bio-electrical signals to provide motion assistance. HAL is available in medical versions (Lower Limb Type, Single Joint Type) and non-medical/consumer versions (Lumbar Type for care and labor support, Lower Limb and Single Joint for wellbeing). Supporting products include Cyvis M100 (medical ECG sensor), Cyin (communication device for disabled individuals), and Acoustic X (photoacoustic imaging). The company also provides Neuro HALFIT service programs at Robocare Centers and at home, along with autonomous cleaning and transport robots. CYBERDYNE operates experience facilities (CYBERDYNE STUDIO and MIRAI ROBO SQUARE) for public engagement.

Differentiator

Problem solved

Functional benefit

Brands

  • HAL (Hybrid Assistive Limb): World's first wearable cyborg; a robotic suit that reads bio-electrical signals from the wearer's skin surface to assist joint movement. Available in lower limb, single joint, and lumbar type variants for medical and non-medical use.
  • Neuro HALFIT
  • Cyvis
  • Cybernics Treatment
  • CYBERDYNE STUDIO
  • MIRAI ROBO SQUARE
  • C-Startup
  • CEJ Fund
  • HCPS Cybernics with Physical AI

Products and services

  • Medical HAL Lower Limb Type Wearable cyborg for medical lower limb rehabilitation targeting patients with spinal cord injuries, stroke, and neurological disorders. Available in standard and small sizes.
  • Medical HAL Single Joint Type Ultra-lightweight (1.5kg) single joint assistance device for intensive training of specific joints (elbow, knee, ankle) in post-operative rehabilitation.
  • HAL Lumbar Type (Care/Wellbeing) Waist-mounted HAL for independence support and care assistance, helping users with sit-to-stand movements and walking while reducing caregiver burden.
  • HAL Lumbar Type (Labor Support) Workplace version of HAL Lumbar Type designed to reduce physical strain during lifting, carrying, and repetitive tasks, including slim models for confined spaces and disaster response applications.
  • HAL Lower Limb Type (Wellbeing) Non-medical version of HAL Lower Limb for general wellness and independence support in daily living activities.
  • HAL Single Joint Type (Wellbeing) Non-medical single joint assistance device for intensive movement training of specific joints for general wellness purposes.
  • Neuro HALFIT Subscription-style comprehensive exercise training program using HAL at Robocare Centers or at home, promoting improvement in brain-nerve-muscular system functions through interactive bio-feedback therapy.
  • Cyvis M100 Medical Vital Sensor Small Holter ECG medical vital sensor capable of approximately 10 days of electrocardiogram measurement on a single charge; cleared as a medical device in Japan with public health insurance coverage.
  • Cyin (Cyin Welfare Device) Innovative communication interface for severely disabled individuals who cannot speak or move, using faint bio-electrical signals from the brain to muscles (motor unit action potentials) to enable yes/no communication and environmental control.
  • Acoustic X Photoacoustic Imaging System Photoacoustic imaging system that integrates optical excitation with ultrasound detection for high-resolution tissue imaging in medical diagnostics.
  • HALTREAD Treadmill Equipment Treadmill equipment designed for HAL-assisted gait training and rehabilitation exercises.
  • CL02 Sterilization/Cleaning Robot Autonomous cleaning and sterilization robot for healthcare facilities and commercial environments.
  • Transport Robot Autonomous mobile robot for material transport and logistics in healthcare and industrial settings.
  • Jukusui Sleep Alarm Device Sleep alarm device designed to improve sleep quality and monitor sleep patterns, operated through subsidiary C2 Inc.
  • MIRAI ROBO SQUARE Exhibition Facility Permanent exhibition facility in Tokyo Shinagawa showcasing Cybernics technologies and HAL to visitors.

Quantifiable outcome

  • Patients with spinal cord injuries able to walk with walker after HAL treatment (e.g., Philippe von Gliszynski walked 1,000+ meters after training)
  • +2 more outcomes

Companies that use Cyberdyne

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Cyberdyne technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Cyberdyne partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered major and core.

  • Japan Fire and Disaster Management Agency (FDMA)majorStrategic or Co-development Partner · 5 June 2026Firefighting-specific model of HAL Lumbar Type selected for field verification of advanced technologies in disaster response operations. CYBERDYNE expanding into disaster prevention and firefighting sectors.
  • Universiti Malaysia PerlismajorStrategic or Co-development Partner · 10 February 2026Comprehensive collaboration agreement for social implementation of HCPS-Integrated Cybernics technology in Malaysia. Part of broader strategy to expand Cybernics ecosystem across ASEAN region.
  • Carnegie Mellon University (CMU)coreStrategic or Co-development Partner · 21 January 2026Strategic MoU for collaborative research in Cybernics and Physical AI. Partnership includes plans to establish Pittsburgh-based joint venture and launch Cyvis health sensor in U.S. market following Japanese medical device approval. Aims to accelerate integration of CYBERDYNE products into U.S. market using Pittsburgh as base for global expansion.
  • Thailand Institute of Geriatric Medicine (IGM-DMS)majorStrategic or Co-development Partner · 14 January 2026Agreement to promote Cybernics Medical and Healthcare Innovation across ASEAN. Part of regional expansion strategy targeting elderly care and rehabilitation markets in Southeast Asia.
  • National Taiwan University (NTU)coreStrategic or Co-development Partner · 18 June 2025MoU signed with National Taiwan University and University of Tsukuba for international collaboration on Cybernics Medical and Healthcare Innovation. National Taiwan University Hospital delegation visited CYBERDYNE headquarters to explore partnership opportunities.
  • PERKESO (Social Security Organisation of Malaysia)coreStrategic or Co-development Partner · 1 January 2018Long-term collaboration since 2018 for large-scale deployment of HAL systems. PERKESO became first organization in Southeast Asia to introduce HAL. National Neuro-Robotics and Cybernics Rehabilitation Centre opened June 2026 with 65 HAL units - one of world's largest single-facility deployments. Collaboration enables patients to access Cybernics Treatment through PERKESO's social security system.
  • BG RCI (Public Workers' Compensation Insurance Institution)majorChannel Partner/ Reseller/ DistributorBusiness partner in Germany for providing Cybernics Treatment at Cyberdyne Care Robotics GmbH in Bochum. Workers' compensation insurance covers HAL treatment costs (approximately €500 per treatment x 60 sessions) for patients with spinal cord injury and stroke.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Cyberdyne competitors and assessment

Company assessment

Direct peers

  • Ekso Bionics: U.S.-listed developer of wearable exoskeletons for medical rehabilitation (stroke, spinal cord injury) and industrial use. Directly comparable to HAL as a hospital- and clinic-deployed lower-limb exoskeleton targeting similar neuro-rehabilitation indications.
  • ReWalk Robotics: Maker of FDA-cleared powered exoskeletons for spinal cord injury and stroke rehabilitation, plus a soft exosuit line. Closely competes with HAL in medical lower-limb neurorehabilitation and shares similar reimbursement-driven go-to-market in the U.S. and EU.
  • Ottobock (suitX): German prosthetics and orthotics leader that acquired suitX, offering modular exoskeletons for industrial and medical applications. Comparable to CYBERDYNE as a wearable robotic-assist player with strong European reimbursement and orthopedic channel access.
  • Parker Hannifin (Indego): Industrial conglomerate whose Indego line delivers FDA-cleared powered exoskeletons for clinical and personal use. Competes directly with HAL in U.S. rehabilitation centers and shares the orthotic-and-assistive positioning.

Broad incumbents

  • Honda Motor (Walking Assist): Large mobility incumbent with a Walking Assist Device for gait rehabilitation and broader humanoid robotics programs (Asimo). Comparable to HAL as a wearable gait-assist technology, though distributed through a much larger automotive and mobility platform.
  • Hyundai Motor Group (Hyundai Robotics / Boston Dynamics): Large mobility conglomerate with wearable robotic exoskeletons and broader humanoid/robotics programs through Boston Dynamics. Adjacent incumbent with overlapping ambition in Physical AI and service/industrial robots, though not a direct medical competitor.

Emerging players

  • Wandercraft: French developer of self-balancing Atalante personal and clinical exoskeletons. Comparable to HAL in the powered lower-limb exoskeleton category with a focus on stroke and spinal cord injury, and competing for European hospital and home-use accounts.
  • Fourier Intelligence: China-based rehab robotics company with ExoMotus exoskeletons and a growing global footprint. Comparable to HAL as a hospital-deployed rehabilitation exoskeleton targeting similar neurological indications, with strong Asia-Pacific overlap.
  • Sarcos Technology and Robotics: U.S. developer of wearable industrial robots and Guardian exoskeletons for workforce augmentation. Comparable to HAL's labor-support and lumbar-assist applications for industrial and defense end-users.
  • German Bionics: European exoskeleton specialist focused on occupational lumbar support (Cray X) for industrial and logistics workers. Direct competitor to HAL Lumbar Type in the labor-support and workplace-safety segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Cyberdyne social profiles

Digital presence

Cyberdyne compliance and trust

Trust signal

Compliance5 records

Cyberdyne financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cyberdyne leadership team

Management profile

Number of profiles

Profiles8 records

Cyberdyne subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Cyberdyne funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cyberdyne M&A and investment

M&A and investment

M&A

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cyberdyne

What does Cyberdyne do?

Cyberdyne develops, manufactures, and sells the wearable cyborg HAL (Hybrid Assistive Limb) and related Cybernics technologies for medical rehabilitation, elderly care, labor support, and consumer wellbeing. It sells and rents HAL devices directly to hospitals, rehabilitation centers, and government healthcare systems, while also running a Robocare Center service network delivering Neuro HALFIT training programs to individuals. Supplementary products include the Cyvis M100 medical ECG vital sensor, Cyin assistive communication device, Acoustic X photoacoustic imaging system, and autonomous cleaning and transport robots.

Is Cyberdyne a public or private company?

Cyberdyne is a public company. It is classified as public and is currently operating.

When was Cyberdyne founded?

Cyberdyne was founded in 2004. It employs 101 to 250 people.

Where is Cyberdyne based?

Cyberdyne is headquartered in Minami, Japan, in the Asia region.

How does Cyberdyne make money?

Four revenue lines are on record. Medical Device Sales and Rental is the primary driver. The others are neuro HALFIT Services, international Projects and Government Contracts and C-Startup/CEJ Fund Investment Returns.

Who are Cyberdyne's main competitors?

Direct peers on record are Ekso Bionics, ReWalk Robotics, Ottobock (suitX) and Parker Hannifin (Indego). Broad incumbents are Honda Motor (Walking Assist) and Hyundai Motor Group (Hyundai Robotics / Boston Dynamics). Emerging players are Wandercraft, Fourier Intelligence, Sarcos Technology and Robotics and German Bionics.

Does Cyberdyne have an API?

No public API is recorded for Cyberdyne.

What industry is Cyberdyne in?

Cyberdyne's product category is Medical Robotics. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesAnnouncement of the start of Holter-type electrocardiogram examination support service utilizing the medical vital sensor Cyvis M100.Cyberdyne Corporation will launch a Holter electrocardiogram support service using the Cyvis M100 sensor on September 18, 2026, with a zero-cost campaign for medical institutions. The service charges a monthly basic fee of 19,800 yen and 7,260 yen per examination, and the company plans to expand measurement items and services for corporations and individuals.Interesting Engineering5 advanced robots supporting patients from surgery to recoveryAn article outlines five robots currently used in healthcare, spanning surgery, infection control, logistics, rehabilitation and therapeutic companionship. It names the da Vinci Surgical System, Xenex LightStrike, TUG, Cyberdyne HAL and PARO, noting FDA approval of da Vinci since 2000 and LightStrike's use at the Mayo Clinic.LinkedInKey Insights and Forecast for Waist Protection Exoskeleton Market (2026-2033): Expected 5.6% CAGR and Segmentation AnalysisThe global Waist Protection Exoskeleton market is projected to grow at a CAGR of 5.6% from 2026 to 2033, driven by increasing demand for worker safety and productivity in industrial sectors. Key market participants include Comau, ULSrobotics, Hyundai, Panasonic, and CYBERDYNE, who are advancing robotics and wearable technologies to support human augmentation. The report highlights regional growth drivers such as safety regulations in Europe and rapid industrialization in Asia-Pacific.LinkedInMedical Rehabilitation Exoskeleton Market Analysis Report 2026-2033: Key Players, Market Size Growth, and Development with a CAGR of 5.4%A market analysis report projects the global Medical Rehabilitation Exoskeleton market will grow at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033, driven by technological advancements and an aging population. The report identifies key industry players including CYBERDYNE, Ekso Bionics, and Parker Hannifin, while noting that North America currently dominates the market with approximately 40% share. Growth is further attributed to increased healthcare expenditures, cross-industry collaborations, and the integration of AI and robotics into rehabilitation solutions.LinkedInNorth America Powered Exoskeleton Market Industry Transformation and GrowthThe North America powered exoskeleton market was valued at USD 1.73 billion in 2025 and is projected to reach USD 7.32 billion by 2035, growing at a CAGR of 15.5% from 2027 to 2035. Growth is driven by increasing adoption in healthcare, industrial safety, and military applications, supported by technological advancements in sensors, materials, and control systems. Key players including Ekso Bionics, ReWalk Robotics, and Cyberdyne are focusing on lightweight, affordable, and AI-integrated devices to expand applications in eldercare, logistics, and construction.PrtimesRehabilitation Robots Market Set to Reach US$ 16.88 Billion by 2033 – PR TimesBusiness Market Insights published a market research report projecting the global rehabilitation robots market to grow from US$7.72 billion in 2025 to US$16.88 billion by 2033, representing a compound annual growth rate of 10.27%. Key growth drivers include the rising global burden of neurological disorders and orthopedic injuries, aging populations, and technological advancements in AI, machine learning, and wearable robotics, with North America currently leading adoption. The competitive landscape includes companies such as CYBERDYNE INC., Lifeward (ReWalk Robotics), Ekso Bionics, Hocoma, Rex Bionics Ltd., and others actively investing in product development and geographic expansion.AijournWhy Physical AI Is the Next Trillion-Dollar Investment OpportunityCYBERDYNE, a Japanese robotics company and pioneer in Cybernics technology, has partnered with Pegasus Tech Ventures to launch a $60 million (JPY 10 billion) corporate venture capital fund targeting Physical AI startups in robotics, healthcare, and intelligent systems. The fund builds on Pegasus's existing investments in Figure AI, an AI robotics company developing autonomous humanoid robots, and Mujin, a developer of intelligent robot control systems for manufacturing and logistics. The article argues that the convergence of advanced AI models, improved robotics hardware, and cloud infrastructure is creating scalable Physical AI businesses, positioning the technology as the next major investment frontier.Global VenturingRobotics pioneer Cyberdyne looks to Silicon Valley for “artificial brain” partnershipsJapanese exoskeleton pioneer Cyberdyne has partnered with Silicon Valley's Pegasus Tech Ventures to launch a ¥10bn ($62m) corporate venture capital fund aimed at building partnerships with AI companies in the United States. The fund marks a strategic pivot for established robotics firms racing to integrate generative AI into physical hardware, addressing the longstanding gap between mechanical excellence and software capabilities. The partnership reflects a broader industry trend where legacy robotics manufacturers seek to secure early relationships with AI "brains" that will power their physical systems, particularly as the sector shifts toward "human assistive" roles.AutomateIndustry Insights: Japanese Exoskeleton Maker Sets out to Fund Silicon Valley Robotics StartupsCyberdyne, a Japanese robotics company known for its exoskeletons, has launched a ¥10 billion ($62 million) corporate venture capital fund in partnership with Pegasus Tech Ventures to invest in Silicon Valley robotics and physical AI startups. The fund will target both seed-stage and Series B companies, requires partnership with Cyberdyne as an investment prerequisite, and aims to allocate at least 50% to Silicon Valley-based companies. The partnership gives startups access to Cyberdyne's networks and supply chains in Japan and Asia, while providing Cyberdyne with inside access to emerging technologies to enhance its existing and future products.Market Research & Business IntelligenceMedical Rehabilitation Robotics Market : Global Industry Analysis 2016Future Market Insights forecasts the global medical rehabilitation robotics market to grow from USD 0.7 billion in 2026 to USD 2.7 billion by 2036, driven by exoskeleton systems and an aging population. Key growth regions include the EU, South Korea, USA, Japan, and the UK, with regulatory compliance and hospital modernization serving as primary demand drivers. Leading companies such as Ekso Bionics, Hocoma AG, and Cyberdyne Inc. are positioned to capture volume through established manufacturing footprints and regulatory approvals.